Lataa...
The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease
Parkinson’s disease is the second most common neurodegenerative disorder; it affects 1% of the population over the age of 65. The number of people with Parkinson’s disease is set to rapidly increase due to changing demographics and there is an unmet clinical need for disease-modifying therapies. The...
Tallennettuna:
| Julkaisussa: | Neural Regen Res |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wolters Kluwer - Medknow
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7059567/ https://ncbi.nlm.nih.gov/pubmed/31997802 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1673-5374.274327 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|